A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp

PHASE3CompletedINTERVENTIONAL
Enrollment

492

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Actinic Keratosis
Interventions
DRUG

Diclofenac sodium

DRUG

Diclofenac sodium

DRUG

Placebo

Trial Locations (30)

24501

The Education and Research Foundation, Lynchburg

27103

PMG Research of Winston-Salem, Winston-Salem

27262

Dermatology Consulting Services, High Point

28401

DermOne of North Carolina, Wilmington

29607

Greenville Dermatology, Greenville

29621

Radiant Research, Anderson

33757

Olympian Clinical Research, Clearwater

33761

Tampa Bay Medical Research, Clearwater

34471

Renstar Medical Research, Ocala

37215

Tennessee Clinical Research Center, Nashville

37917

Dermatology Associates of Knoxville, Knoxville

37922

The Skin Wellness Center, Knoxville

40202

DS Research, Louisville

45249

Radiant Research, Cincinnati

73112

Lynn Health Science Institute, Oklahoma City

75024

ACRC Trials, Plano

77056

The Center for Skin Research, Houston

78229

Dermatology Clinical Research Center of San Antonio, San Antonio

78249

Stephen Miller, M.D., San Antonio

78759

DermResearch, Inc., Austin

80220

Horizons Clinical Research Center, Denver

84117

Dermatology Research Center, Salt Lake City

85202

Agave Clinical Research, Mesa

85712

Radiant Research, Inc., Tucson

90404

Clinical Science Institute, Santa Monica

92108

Medical Center for Clinical Research, San Diego

92123

TCR Medical Corporation, San Diego

94538

Center for Dermatology Clinical Research, Inc., Fremont

99202

Premier Clinical Research, Spokane

02886

Omega Medical Research, Warwick

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT02611804 - A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp | Biotech Hunter | Biotech Hunter